INTERNATIONAL PATENT: SAGE THERAPEUTICS, INC., A WHOLLY OWNED SUBSIDIARY OF SUPERNUS PHARMACEUTICALS, INC., BIOGEN MA INC. FILES APPLICATION FOR "PROCESS FOR PRODUCING A GABA RECEPTOR MODULATOR"

GENEVA, March 19 -- SAGE THERAPEUTICS, INC., A WHOLLY OWNED SUBSIDIARY OF SUPERNUS PHARMACEUTICALS, INC. (9715 Key West Ave.Rockville, Maryland 20850), BIOGEN MA INC. (225 Binney StreetCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/044475) for "PROCESS FOR PRODUCING A GABA RECEPTOR MODULATOR" on Sep 02, 2025. With publication no. WO/2026/055127, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COLLIER, Stephen (c/o Sage Therapeutics, Inc.9715 Key West Ave.Rockville, Maryland 20850), FORNICOLA, Richa...